Prof. Sanaba BOUMBALY | Health Sciences | Stellar Contributions to Science Award

Prof. Sanaba BOUMBALY | Health Sciences | Stellar Contributions to Science Award

Prof. Sanaba BOUMBALY, Centre de Recherche en Virologie, Guinea

Prof. Sanaba Boumbaly, PhD, is a leading expert in microbiology and epidemiology, currently serving as the Director General of the Center for Research in Virology and the Laboratory of Hemorrhagic Fevers of Guinea (CRV-LFHVG) since 2022. She has held prominent positions in the field of tropical infectious diseases in Guinea, including Director of the International Research Center on Tropical Infections (CIRIT) and the School of Doctoral Studies at the Institute of Applied Biology Research of Guinea (IRBAG). Prof. Boumbaly has significantly contributed to the understanding of viral hemorrhagic fevers, arboviruses, hepatitis, and HIV/AIDS.

Profile

Scopus

Strengths for the Award

Professor Sanaba Boumbaly presents a stellar profile, making her a strong candidate for the “Stellar Contributions to Science Award.” Her extensive experience in virology, especially in managing and leading national reference laboratories, showcases her leadership in combating infectious diseases like Ebola, Marburg, and Zika. She has contributed significantly to viral hemorrhagic fevers and arbovirus research, and her findings on various viruses like Ebola in bats, Marburg, and Zika in Guinea are critical. Her role in publishing over 52 scientific papers and collaborating with global health institutes demonstrates her impact on global health research.

Areas for Improvement

While Professor Boumbaly’s expertise in viral hemorrhagic fevers is notable, expanding her research impact to include more interdisciplinary collaborations outside tropical infections could strengthen her international recognition. Additionally, focusing more on capacity building in local research institutions and translating findings into more public health interventions could elevate her contributions further. Broadening her role in policy-making and training young scientists may also add value to her already impressive portfolio.

Education ๐ŸŽ“

Prof. Boumbaly earned her PhD in Microbiology and Epidemiology in 1994, following a DESS in 1991 and DES in 1983. She has completed several advanced training programs, including molecular diagnostic methods for viral hemorrhagic fevers like Ebola, Marburg, and Lassa (2016), as well as biosafety, biosecurity, and molecular diagnostic techniques for hepatitis and HIV/AIDS (2016 & 2020).

Experience ๐Ÿ†

Prof. Boumbaly has more than three decades of research and leadership experience. She directed multiple high-profile research institutes, including CIRIT and IRBAG. She has mentored numerous doctoral and masterโ€™s students, with 8 PhD students and 25 masterโ€™s students under her supervision. Her extensive teaching career includes virology and medical bacteriology at various universities and research institutes in Guinea.

Research Interests ๐Ÿ”ฌ

Prof. Boumbaly’s primary research areas are viral hemorrhagic fevers, hepatitis, HIV/AIDS, arboviruses, and emerging infectious diseases. Her work focuses on molecular diagnostics, epidemiology, and genomic surveillance of viral pathogens like Ebola, Marburg, and Mpox, with partnerships extending to prestigious institutes such as the Institut Pasteur and the Central Institute of Epidemiology in Moscow.

Awards ๐Ÿ…

Prof. Boumbaly is a member of the Guinea Academy of Sciences since 2024 and holds numerous other distinctions, including leadership roles in global genomic surveillance initiatives for arboviruses and hemorrhagic fevers. She has contributed to national and international collaborations, significantly advancing the research on viral epidemics in Guinea.

Publication Top Notes ๐Ÿ“š

Experience with HCV detection and Molecular Genetic CharacterizationMicroorganisms (2023)

Marburg virus in Egyptian Rousettus bats in GuineaPLOS Neglected Tropical Diseases (2023)

Bombali virus in Mops condylurus Bats, GuineaMaladies Infectieuses Emergentes (2019)

The First Case of Zika Virus Disease in GuineaViruses (2023)

Hepatitis B drug resistance mutations in pregnant womenProblems of Virology (2023)

Conclusion

Professor Boumbaly’s significant contributions to virology and public health in Guinea and beyond make her an excellent contender for the “Stellar Contributions to Science Award.” Her leadership, groundbreaking research, and influence in the field of infectious diseases underscore her scientific excellence, though broadening her interdisciplinary collaborations and policy impact could further enhance her legacy.

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Medical Innovation Award

Assist Prof. Dr. Andrea Marino | Medicine and Health Sciences | Best Researcher Award

Assist Prof. Dr. Andrea Marino, Senior Researcher, University of Catania, Italy

๐ŸŒŸ Assist Prof. Dr. Andrea Marino ๐ŸŒŸ, a distinguished Senior Researcher at the University of Catania, Italy ๐Ÿ‡ฎ๐Ÿ‡น, is making significant strides in Medicine and Health Sciences. ๐Ÿฅ๐Ÿ”ฌ With a profound dedication to advancing medical research and improving healthcare outcomes, Dr. Marino’s work is exemplary. His groundbreaking studies and innovative approaches are pivotal in pushing the boundaries of medical science. ๐Ÿงฌโœจ As a nominee for the Best Researcher Award, his contributions continue to inspire and shape the future of health sciences. ๐Ÿ‘๐Ÿ† His dedication and impact are truly remarkable, setting a high standard for excellence in research. ๐ŸŒŸ๐Ÿ”ฌ๐Ÿ“š

PROFILE ๐Ÿ“

Googlescholar, Orcid

EDUCATION AND TRAINING ๐ŸŽ“

Prof. Dr. Andrea Marino ๐ŸŒŸ has been serving as an Associate Professor in the field of Skin, Infectious, and Gastrointestinal Diseases since February 2023 at the National Scientific Qualification. ๐ŸŽ“ He is also pursuing a PhD in Basic and Applied Biomedical Sciences at the University of Catania, Italy, since November 2021. ๐Ÿงฌ Dr. Marino is an Infectious Diseases Specialist at the University of Messina since December 2021. ๐Ÿฅ He has held a medical license from Ordine dei Medici Catania since March 2017. ๐ŸŽ“ Additionally, he earned his degree in Medicine from the University of Catania in July 2016. ๐Ÿฉบ He has been an Italian Red Cross Volunteer since August 2012. ๐Ÿš‘

WORK EXPERIENCE ๐Ÿ’ผ

๐Ÿ”ฌ Assist Prof. Dr. Andrea Marino is an Assistant Professor/Senior Researcher in Infectious Diseases at the University of Catania, Italy, since May 2024. Previously, he was a Junior Researcher at the same institution. Since March 2020, he has been serving as a Medical Doctor for COVID-19 at ARNAS Garibaldi, Catania. Dr. Marino also completed his residency in Infectious Diseases at ARNAS Garibaldi (2017-2021) and received the SIMIT Research Grant in 2017. He is a Teaching Assistant, Editorial Board Member for multiple journals, and a Volunteer Reviewer at MDPI Journals. ๐Ÿฆ ๐Ÿ“š๐Ÿ‘จโ€โš•๏ธ

Editorial Board Member ๐Ÿ“๐Ÿ‘ฅ

๐Ÿ”ฌ Assist Prof. Dr. Andrea Marino is a distinguished researcher contributing to PLOS ONE. ๐ŸŒŸ With a robust background in [specific research area], Dr. Marino excels in advancing scientific knowledge through innovative methodologies and rigorous analysis. ๐Ÿ“Š Their work focuses on [briefly describe research focus], aiming to address critical challenges and drive impactful discoveries. ๐ŸŒ Passionate about open-access science, Dr. Marino is dedicated to ensuring research findings are accessible to a global audience, fostering collaboration and knowledge sharing. ๐Ÿ“š Their commitment to excellence and collaboration makes them a valuable asset to the scientific community. ๐Ÿค๐Ÿ”

PUBLICATION TOP NOTES ๐Ÿ“š

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study

Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)

Malignant melanoma in HIV: Epidemiology, pathogenesis, and management

Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey

Non-AIDS defining cancers: a comprehensive update on diagnosis and management.

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability

Managing adult patients with infectious diseases in emergency departments: international ID-IRI study

Ampicillin Plus Ceftriaxone Regimen againstย Enterococcus faecalisย Endocarditis: A Literature Review

Rapid emergence of cryptococcal fungemia, Mycobacterium chelonae vertebral osteomyelitis and gastro intestinal stromal tumor in a young HIV late presenter: A case report